NCT06377696View on ClinicalTrials.gov

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
Malignant Brain Neoplasm
Interventions
OTHER

Best Practice

Receive SOC

OTHER

Medical Device Usage and Evaluation

Wear wearable device

DRUG

Metformin

Given PO

OTHER

Neurocognitive Assessment

Undergo neurocognitive test

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06377696 - Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy | Biotech Hunter | Biotech Hunter